Everything Money

ㅤ

Get access to all the tools. Join today.
Ocular Therapeutix's eye drug superior to Regeneron's Eylea in late-stage trial

Ocular Therapeutix's eye drug superior to Regeneron's Eylea in late-stage trial

Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron's approved treatment Eylea in a late-stage trial.

REGN -1.20%

Latest

Treasury Yields Fall to 2026 Lows as Investors Flock to Bonds
Fed's Barr Wants Proof Goods Inflation Is Retreating Before Additional Rate Cuts
Anthropic Has Another New Model—Software Stocks Are Going To Hate It
Fed must dig deep on AI impact to make right rate calls ahead, Daly says
Why Investors Are Quietly Rotating Out Of Semiconductor Stocks
Wall Street Loves This Crypto IPO. Bitcoin's Slide Isn't a Problem, Analysts Say.
Forget AI—Tax Refunds Could Give Retail Stocks a Lift
Tech Stocks Dip as AI Doubts Linger on Wall Street
Drop in unauthorized immigration slows job growth, SF Fed paper finds
AI Spending Fears May Be Overdone as the Tech Selloff Reshapes the Market
Featured content

Earnings Calendar

Everything Money Logo
There is 1 spot left to Join Everything Money Today

U.S. markets are closed and will reopen tomorrow at 9:30 AM

Top Searches >

Symbol
Last Price
Change
% Change
Company LogoAAPL
263.88
+8.10
+3.17
Company LogoPYPL
40.81
+0.52
+1.29
Company LogoADBE
260.45
-3.52
-1.33
Company LogoAMZN
201.15
+2.36
+1.19
Company LogoMSFT
396.86
-4.46
-1.11

Top Gainers >

Symbol
Last Price
Change
% Change
Company LogoFISV
63.45
+4.09
+6.89
Company LogoLITE
600.42
+37.68
+6.70
Company LogoALNY
332.61
+18.21
+5.79
Company LogoCEG
303.01
+14.58
+5.05
Company LogoMT
64.25
+2.74
+4.45

Top Losers >

Symbol
Last Price
Change
% Change
Company LogoVMC
302.19
-25.46
-7.77
Company LogoGFI
51.41
-3.19
-5.84
Company LogoSNDK
590.59
-35.97
-5.74
Company LogoMFG
9.35
-0.55
-5.56
Company LogoCDNS
283.46
-16.00
-5.34

Latest Videos

Trending Analysis

See all